COMMUNIQUÉS West-GlobeNewswire

Merit Medical Announces Appointment of Two New Directors
03/01/2019
SOUTH JORDAN, Utah, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Aptevo Therapeutics Collects $3.3 Million In Escrow Funds From Saol Therapeutics
03/01/2019
SEATTLE, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, announced today that it has collected $3.3 [...]
New Prediction Feature for Hypoglycemia Now Available in Sugar.IQ(TM) Personal Diabetes Assistant App, Developed by Medtronic and IBM Watson Health
03/01/2019
IQcast Feature Aims to Predict the Likelihood of a Low Glucose Event Up to Four Hours in Advance DUBLIN and CAMBRIDGE, Mass. - January 3, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, [...]
Cerner and CoverMyMeds Collaborate to Improve Prescription Price Transparency Within the EHR
03/01/2019
KANSAS CITY, Mo., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cerner, a global leader in health care technology, has collaborated with CoverMyMeds to integrate patient-specific information into the electronic health record (EHR) [...]
Avalon GloboCare Establishes Joint Venture with Arbele Limited to Co-develop Next-Generation Multi-Targeted CAR-T Cellular Immunotherapy
03/01/2019
FREEHOLD, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies, announced today that the Company and its wholly owned subsidiary, Avactis [...]
Tizona Therapeutics Appoints Scott Clarke as Chief Executive Officer and Provides Update on Regulatory Milestone for its First-in-Class CD39 program in Cancer
03/01/2019
– New Leader to Guide Immunotherapy Biotech in its Next Phase of Growth – – FDA Accepts Tizona’s Investigational New Drug Application for TTX-030 – SOUTH SAN FRANCISCO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Tizona [...]
Diffusion Pharmaceuticals Executes Successful NASDAQ Compliance Plan: Company Will Remain Listed on NASDAQ Stock Market
03/01/2019
CHARLOTTESVILLE, Va., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) , a cutting-edge biotechnology company developing new treatments for life-threatening medical conditions by improving [...]
Arbor Biotechnologies Announces New Discoveries and Addition to its Board
03/01/2019
Discovers three new CRISPR-Cas systems, findings published in the journal Science Appoints Paul Meister to its Board of Directors CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor), an [...]
Genmab to Present at the 37th Annual J.P. Morgan Healthcare Conference
03/01/2019
Media Release Copenhagen, Denmark, January 3, 2019 Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the 37 th Annual J.P. Morgan Healthcare [...]
CV Sciences, Inc. Named One of the First U.S. Hemp Authority™ Certified Manufacturers
03/01/2019
Continuing its commitment to excellence, the Company is proud to announce this landmark certification. LAS VEGAS, Jan. 03, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc . (OTCQB: CVSI) (the “Company”, “we” or “our”), a [...]
RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors
03/01/2019
Glen Rock, N.J, Jan. 03, 2019 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a clinical stage pharmaceutical company, focused on the development of medicines that [...]
FIT Biotech Oy: FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI rules.
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET FIT Biotech has received a notice from the Finland Arbitration Institute concerning the request by Bracknor Invest to initiate arbitration proceeding under the FAI [...]
FIT Biotech Oy: Changes in FIT Biotech's Board of Directors
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET Changes in FIT Biotech's Board of Directors Juhani Pitkäkoski has resigned because of personal reasons from FIT Biotech Oy's ("Company", FITBIO: FN Finland) Board of [...]
FIT Biotech Oy: Changes in FIT Biotech's management
03/01/2019
FIT Biotech Oy Company release 3.1.2019 at 15:30 EET Changes in FIT Biotech's management Kalevi Reijonen, FIT Biotech Oy's ("Company", FITBIO: FN Finland) Chief Medical Officer and a member of the Management Team, will [...]
Avadel Pharmaceuticals Announces Changes to Management Team and Board of Directors
03/01/2019
- Michael S. Anderson resigns as Chief Executive Officer and member of Avadel’s Board of Directors – - Gregory J. Divis, current Avadel Chief Operating Officer, named Interim Chief Executive Officer – - Geoffrey M. [...]
Cellectar Biosciences to Present at the Biotech Showcase
03/01/2019
FLORHAM PARK, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted [...]
ISS and Glass Lewis Recommend MPX Securityholders Vote in Favour of the Arrangement and MPX Shareholders Vote in Favour of the MPX Continuance and the MPX International Stock Option Plan
03/01/2019
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE: MPX) (OTC:MPXEF) (the “Company” or “MPX”) is pleased to announce that Institutional Shareholder Services Inc. (“ISS”) and Glass Lewis and Co [...]
Wildflower Opens First New York CBD Retail Store
03/01/2019
VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN) (the “Company”) is excited to announce the opening of its first Wildflower by Bridges General store in Lower Manhattan at [...]
Pluristem Concludes Positive Meeting with FDA on Development Plan for Acute Radiation Syndrome
03/01/2019
Meeting included representatives from NIH and BARDA HAIFA, Israel, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel [...]

Pages